Historical controlled studies of methandienone in weightlifters reported changes in strength and body weight, but were small and short. They do not establish long-term safety or the effects of modern combined-drug use.
Key points
- The published athletic trials were conducted decades ago with small samples.
- Weight changes can reflect fluid as well as tissue.
- Historical controlled exposure cannot define current product purity or cumulative risk.
What the literature shows
Freed and colleagues reported a double-blind crossover study involving trained athletes. Short-term performance observations were made in a narrow group; outcomes cannot be generalized to all users or prolonged exposure.
A related crossover investigation in weightlifters described effects of anabolic steroids on weight and performance. Designs and analytical methods of the 1970s cannot answer today's long-term cardiovascular and liver safety questions.
What remains unknown
- Long-term outcomes under current use patterns are not established.
- The proportion of short-term body-weight change attributable to lasting muscle gain is uncertain.
Safety and monitoring implications
- Oral anabolic drugs can affect the liver and blood lipids; symptoms or abnormal results deserve medical assessment.
- No short trial can rule out delayed cardiovascular or reproductive harm.
Cited literature
- 1.Freed DLJ, Banks AJ. (1975). A double-blind crossover trial of methandienone (Dianabol, CIBA) in moderate dosage on highly trained experienced athletes. British Journal of Sports Medicine. Find on PubMed
- 2.Freed DLJ, Banks AJ, Longson D, et al. (1975). Anabolic steroids in athletics: crossover double-blind trial on weightlifters. BMJ. Find on PubMed
Community reports
Anecdotal — not scientific evidence
Lived experience is valuable context and often surfaces problems before the literature does. It is also uncontrolled, unverified and subject to bias, so it never overrides published findings here.
Editorial evidence status
MixedNo independently verified community reports were available for this analysis. Anecdotes have not been invented or treated as clinical evidence.
Buying Methandienone / methandrostenolone in Australia: what to check first
APEDRA does not sell Methandienone / methandrostenolone or any other product, and takes no commission from suppliers. If you are researching where to buy it, the biggest practical risk is not the compound itself but what is actually in the bottle: under-dosing, substitution with a different compound, and contamination are all documented in independent testing of online research chemicals.
- Ask for a batch-specific third-party lab report (HPLC/mass spectrometry), not a generic certificate.
- Check independent review platforms, not only reviews hosted on the seller's own site.
- Read the shipping, returns and refund policies before ordering.
- Be wary of prices far below the market or exaggerated results claims.
Compare Australian vendors independently · how we assess suppliers
Terms used here are defined in our glossary, and the evidence-grading scale explains what this analysis's grade means. If you believe something here is wrong, tell us.
This analysis is educational. It is not medical advice, a dosing recommendation, or an endorsement of use. Speak with a qualified medical practitioner about your circumstances.